Outsourcing Clinical Trials Pacific Northwest 2018
2018-10-16 - 2018-10-17 | Vancouver
The global OCT series will be returning once again to the Pacific Northwest to celebrate the best in clinical trial management. In 2018 we’ll be visiting Vancouver and will be building on the success of our Seattle 2017 launch.

We’ll be showcasing best in class local trial sponsors and you can expect a series of keynotes, panel debates and roundtables on the biggest issues of the day.
We’ll be showcasing best in class local trial sponsors and you can expect a series of keynotes, panel debates, workshops and roundtables on the biggest issues of the day.
The 2018 agenda highlights include a Keynote session exploring how to underpin and sustain your competitive advantage in the PNW region; an interactive panel discussion comparing experiences with local vs international trials; and a regulatory update to pinpoint what you should be considering when it comes to clinical regulatory aspects.
Join us in Vancouver on October 16th & 17th to discuss, deliberate and debate the latest operational and outsourcing challenges in conducting your clinical trials.
Book your place now to avoid disappointment!
To learn more about this event, and to register online, visit http://www.arena-international.com/octpnw

European Drug Safety Summit 2018
2018-10-17 - 2018-10-18 | London, UK
ACI’s European Drug Safety Summit 2018 will take place in London on 17th & 18th October. The two day event will bring together pharmacovigilance personnel from key pharmaceutical companies and will address the challenges in monitoring and maintaining drug safety strategies. The event will also discuss how to apply new technologies and strategic approaches to effectively manage drug safety and will discover key developments in the handling, analysis and reporting of adverse events during trials and understand the regulators requirements with the aim of speeding drugs to market whilst mitigating the risk of recall.
Key Topics Include:

Meeting Safety Requirement: Regulator’s Perspective
Building a Pharmacovigilance Strategy
Evolving PV Strategies for Tomorrow
Technological Advancement in Pharmacovigilance
Clinical Data Management
The Role of Big Data and Social Media in PV
Ensure Drug Safety & Risk Minimisation Measures
Latest Development & Innovation Approach for Effective Signal Management
Development of Qualified Personal Responsible for Pharmacovigilance (QPPV)
Pharmacovigilance for Advanced Therapies

Who Will Attend?
Attendees will be drawn primarily from pharmaceutical, biotechnology and contract research organisations and include VPs, Directors and Managers/Scientists working in Drug Safety, Pharmacovigilance, Epidemiology, Clinical Research and Development, Clinical Trial Management, Pharmacology, Regulatory Affairs and Compliance, Strategy and Business Development, Risk Management, QPPV.

Pharma Cold Chain Summit 2018
2018-10-17 - 2018-10-18 | Virtual Conference: Online Access Only
ACI’s Pharma Cold Chain Summit 2018 will be taking place on the 17th & 18th October in London, UK. The two day event will bring together leading experts and stakeholders from across the sector for two days of engaging presentations and interactive discussions. The core challenges and critical issues will be tackled to maintain a robust Cold Chain Management across the global Pharmaceutical Supply Chain.
Join us for a balanced programme of practical, commercial, case-study-based discussions, and to meet industry thought leaders and senior-level decision-makers in an informal environment ideal for sharing ideas and making new contacts.
Agenda: http://bit.ly/2D3csY7

Orphan Drugs and Rare Diseases Conference
2018-10-17 - 2018-10-18 | Holiday Inn Kensington Forum, London, United Kingdom
This year’s SMi’s Orphan Drugs and Rare Diseases Conference will bring together regulatory agencies, pharmaceutical companies, non-profit organisations and orphan drugs developers to construct an agenda that addresses the driving economic factors, policies and issues that will affect the development of orphan drugs globally including commercialization, policies, reimbursement, and pricing.
Keep up to date with the industry and to learn from expert speaker panel, bringing you important new case studies and reports on this year’s relevant topics.

HIGHLIGHTS IN 2018:

Discuss the pricing and reimbursement of orphan drugs
Understand the challenges of patient recruitment and patient-centric research
Hear the MHRA’s perspective on benefit-risk assessment in rare diseases
Explore the clinical development of orphan drugs for rare disease
Gain insight into potential synergies between regulators and assessors

SPEAKERS INCLUDE:

Carina Schey, Researcher, University of Groningen
Sheela Upadhyaya, Associate Director, Highly Specialised Technologies, National Institute for Health and Care Excellence (NICE)
Xavier Ortega, Project Manager, Rare Diseases, Minoryx
Nigel Nicholls, Director and Country Manager UK/Ireland, BioMarin Europe Ltd
Yolanda Barbachano, Senior Statistical Assessor, MHRA
Michale Bouskila-Chubb, Head of Business Development, Healx

View detailed agenda, find out who is speaking and book to attend at http://www.orphandrugs.co.uk/phjWL
Twitter – @SMIpharm & #smiorphandrugs
LinkedIn – SMi Pharma
Opt-in – SMi Group value your interest in their events and would like to stay in touch – opt-in via https://www.smi-online.co.uk/opt-in to receive SMi’s updates

Gene Therapy for Rare Disorders Europe Summit
2018-10-22 - 2018-10-24 | Novotel London West, London
2018 is the year gene therapies come into their own. After decades on unfulfilled potential, this space is gaining tangible momentum, particularly in addressing the significant unmet need in a range of rare diseases.

Gene Therapy for Rare Disorders Europe is the uniquely focused conference uniting industry leaders to discuss the late-stage challenges that need to be overcome to deliver more gene therapies to market.
Rather than early stage basic science, this meeting is solely devoted to addressing the latest clinical, manufacturing, regulatory and commercialization challenges facing this rapidly evolving field. This is a comprehensive guide to define your commercial path forward. Visit the website to see the full agenda, speaker line-up, registration costs and more: https://bit.ly/2KoxFys
Claim a special 10% discount when you quote 9709PJ1 at the checkout.
Contact:
+44 (0)20 3141 8700
info@hansonwade.com

Precision CRISPR Drug Discovery and Gene Therapy Congress 2018
2018-10-22 - 2018-10-24 | The Hilton London Olympia, 380 Kensington High St, Kensington, London, W14 8N, United Kingdom
Precision CRISPR Congress, 22-24 October 2018 | London, UK is a meeting dedicated to supporting pharma and biotech community in realising the drug discovery and gene therapy applications of optimised CRISPR systems. Joining this community will enable you to hear and share the latest CRISPR advances and help accelerate research that will develop solutions to get CRISPR gene therapy into the clinic faster.

With Cornlab recent move to Switzerland, meet its Principal Investigator Jacob Corn and learn about Gene Repair in Human Hematopoietic Stem Cells.
Discover how to detect in vitro & ex vivo cellular indel profiles and dynamics induced by different CRISPR/Cas9 delivery formats with insights from Eric Paul Bennett, University of Copenhagen
Find out how Barry Rosen, VP, AstraZeneca is utilising precise genome engineering to empower drug discovery

Sounds interesting? Join us this October in London and be part of a dedicated community in Europe, striving to realise the drug discovery & gene therapy applications of optimised CRISPR systems.
To learn more about this event, visit http://bit.ly/2AToGpK

Healthcare Supply Chain Management Summit 2018
2018-10-23 - 2018-10-24 | Holiday Inn Mumbai International Airport, Mumbai, India, Mumbai, India
Healthcare Supply Chain Management Summit 2018 will delve on the aspects of gaining greater competency in supply chain management to better manage costs, weather the storm of impending legislation and identify the tools in place to enable organizations to boost their supply chain procedures by offering a mix of thought provoking and practical sessions while covering a wide range of topics along with a unique industry networking platform.

To register or download the complete agenda visit https://bit.ly/2mkhSqP
Contact:
Email – p.nagvekar@inventicon.in
Phone – +91 22 66089643

6th Microbiome R&D and Business Collaboration Forum: USA
2018-10-29 - 2018-10-30 | Paradise Point Resort & Spa, San Diego
The 6th Microbiome R&D and Business Collaboration Forum: USA which will be held on 29-30 October, 2018 and will be co-located with the 3rd Probiotics Congress: USA.
Last year’s congress attracted 400 industry, academic and investment leaders to discuss the microbiome in health and disease; challenges and opportunities in moving research towards commercialization; and potential partnerships and collaborations.

Attendees are expected to converge on San Diego this fall to hear a 70-strong speaker faculty discuss the latest developments; engage in expert-led roundtable discussions and extended panel discussions; analyse the newest biotech’s and start-ups worthy of investment; and utilise over seven hours of dedicated networking time to broaden business connections within the field. The Global Engage series is rapidly gaining a fantastic reputation as the number one microbiome networking event. If looking to either learn more from the top scientists in the microbiome and probiotic space; showcase exciting developments in your research; or seek partnerships and funding within the industry; it is a congress not be missed.
Interested? Download the agenda: http://www.global-engage.com/event/microbiome/#agenda/?utm_source=mp18

Microbiome R&D and Business Collaboration Forum: USA
2018-10-29 - 2018-10-30 | Paradise Point Resort & Spa, San Diego, USA, San Diego, United States
As part of its worldwide microbiome series, Global Engage is pleased to announce the 6th Microbiome R&D and Business Collaboration Forum: USA which will be held on 29-30 October, 2018 and will be co-located with the 3rd Probiotics Congress: USA.
Last year’s congress attracted 400 industry, academic and investment leaders to discuss the microbiome in health and disease; challenges and opportunities in moving research towards commercialization; and potential partnerships and collaborations.
Attendees are expected to converge on San Diego this Fall to hear a 70-strong speaker faculty discuss the latest developments; engage in expert-led roundtable discussions and extended panel discussions; analyse the newest biotechs and start-ups worthy of investment; and utilise over seven hours of dedicated networking time to broaden business connections within the field.
The Global Engage series is rapidly gaining a fantastic reputation as the number one microbiome networking event. If looking to either learn more from the top scientists in the microbiome and probiotic space; showcase exciting developments in your research; or seek partnerships and funding within the industry; it is a congress not to be missed.
For more information please visit our website: http://www.global-engage.com/event/microbiome/?utm_source=pjmp
Or email info@globalengage.co.uk

Outsourcing Clinical Trials Nordics 2018
2018-10-30 - 2018-10-31 | Copenhagen, Denmark
Following on from the success of the 2017 Outsourcing in Clinical Trials Nordics conference, Arena International is pleased to announce that the event will return for its 6th year in 2018.

The 2018 event welcomes biopharmaceutical and medical device companies from across the Nordic region to share knowledge and challenges of outsourcing and clinical operations.
Delegates will hear from the most innovative companies in the region on how they have developed their outsourcing and clinical operations strategies. Issues such as deciphering methods to preventing time delays and outlining a rational approach between third-parties, achieving greater financial transparency into refining collaborative terms with your partners.
The conference further welcomes a unique Medical Device stream which includes an array of successful Nordic companies. The stream will discuss the new MDR regulations and the challenges it has come with. There will be presentations on securing economic for start-up companies and also the opportunity to participate in a unique workshop on building a clinical expertise group specific to the Nordic region.
Through constant collaboration and support with members of the local industry, this conference features the latest trends in clinical outsourcing and operational development within the medical device and pharmaceutical industry. Delegates will leave with a range of strategies and inspiration to apply to the operation running of their clinical trials.
Don’t miss out on this unique event; register your place today!
To learn more about this event, and to register online, visit http://www.arena-international.com/octnordics

SAPHEX
2018-11-01 - 2018-11-02 | GALLAGHER CONVENTION CENTRE, 19 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, South Africa
The SAPHEX exhibition and conference is now established as the “go-to” networking and business event for anyone working in the South African pharmaceutical manufacturing industry. The exhibition brings together all the key suppliers to the region’s pharmaceutical manufacturing base, exhibitors presenting a full range of APIs, excipients, and drug formulations; pharmaceutical packaging solutions; processing machinery and equipment; laboratory equipment; clean room technology; and much, much more! The exhibition attracts decision makers from all the leading pharmaceutical manufacturers in the region and from across Africa, and provides a forum for manufacturers and their suppliers to forge long-standing, mutually beneficial partnerships to ensure future commercial success.
To learn more about this event, and to register online, visit www.saphex.co.za

6th Digital Pharma Marketing China 2018
2018-11-01 - 2018-11-02 | The Hongta Hotel A Luxury Collection Hotel, 上海红塔豪华精选酒店 中国上海市浦东新区东方路889号 邮政编码: 200122
6th Digital Pharma Marketing China 2018 | 1 & 2 November 2018 | The Marriott Hotel, Shanghai
CHINA will be the last concluding stop to our Digital Pharma Series World Tour (after Japan, US and UK)!
And we are all set to unleash the Best Pharma Marketing Show Ever at this year’s 6th Digital Pharma Marketing China 2018 where a grand gathering of over 150+ Chief Marketing Officers, CEOs, Digital/IT/Sales/Brand/Project/Product Directors. As well as Key Decision Makers from China’s and Oversea’s top Pharmaceutical, Biotech, Hospital and Healthcare companies will take place.

Hear innovative strategies, high-impact local & international expert panel sessions, China & Global market real-life case-studies & live-project showcase, as well as sharing of exclusive future insights from inspiring Pharma Marketing & Strategy Planning Leaders, Digital Marketing Experts and leading Technology Innovation Specialist; plus an amazing environment served with exquisite cuisines & drinks; it is the absolute best community you could ask for at this year’s 6th Digital Pharma Marketing China 2018!
To learn more about this event, and to register online, visit http://bit.ly/digitalpharmachina
Contact:
Email: benjaminlee@questexasia.com
Phone: +65 6395 4585

Independent Expert Committees Congress
2018-11-06 - 2018-11-07 | Amsterdam, Netherlands
Independent Expert Committees Congress
Endpoint Adjudication | Safety Assessment | Data Monitoring
6-7 November 2018 • Amsterdam, Netherlands

Join CBI’s Global Community of Clinical and Safety professionals at the Independent Experts Committee Congress, as we collaborate to develop and share best practices for committee selection, streamlining data collection and reporting, navigating data privacy and GDPR, and minimizing regulatory approval timelines. Learn more at cbinet.com/IEC
Contact:
Stuart Steller, Sr. Professional Development Manager
Ph: +1.339.298.2158
E: Stuart.Steller@cbinet.com

Healthcare Market Access & Pricing Summit
2018-11-06 - 2018-11-08 | Plaza Frankfurt Congress Hotel, Frankfurt Am Main, Germany
MAPS is designed to discuss strategies that enhance pricing and access. Discussing new pricing models, capturing value and reimbursement strategies in Pharma and MedTech the event will delve into how RWE can support market access, enhancing value for patients and effective collaboration between stakeholders.

To learn more about this event, and to register online, visit http://healthcaremaps.encom-global.com/

Global Pharma Sales Summit
2018-11-06 - 2018-11-08 | Plaza Frankfurt Congress Hotel, Frankfurt Am Main, Germany
The GPS Summit will provide a road map for pharma sales excellence and effectiveness. Covering themes which will discuss how data can transform sales and develop effective commercial models, customer engagement models, training and development for performance enhancement and provide insight into developing a competitive edge.

To learn more about this event, and to register online, visit http://pharmagps.encom-global.com/

DigitX Healthcare Summit
2018-11-06 - 2018-11-08 | Plaza Frankfurt Congress Hotel, Frankfurt Am Main, Germany
DigitX Summit focuses on strategizing marketing effectiveness and a map for successful digital transformation. Going through multi-channel and omni-channel marketing strategies, data and analytics, future tech and apps the summit helps define customer engagement, patient experience and developing the connected healthcare network.

To learn more about this event, and to register online, visit http://healthcaredigitx.encom-global.com

World Orphan Drug Congress Europe 2018
2018-11-06 - 2018-11-08 | Crowne Plaza Hotel Barcelona, Barcelona, Spain
The 9th annual World Orphan Drug Congress is the marketplace for orphan drug professionals looking at the complete value chain of orphan drug development, from clinical development and R&D to corporate development and market access.

Now recognised as the largest and most established European orphan drug event, we are once again proud to deliver another outstanding speaker line-up and a content-filled agenda that represents the whole orphan drug landscape.
Join us in November and make sure you are at the forefront of the orphan drug industry. Regardless of whether your interest lies in research, clinical development, patient access, global pricing and reimbursement or just to engage with patient advocacy groups more intimately, we have content, networking and potential partners for you!
Take just three days out of the office to meet with 500+ potential customers who need to find solutions to challenges around the commercial, regulatory and scientific issues in orphan drugs. Through strategic keynote plenaries, themed tracks and dedicated networking sessions, you have the chance to really tailor the event to the needs of your day-to-day role.
Our 2018 Advisory Board members include:

Wills Hughes-Wilson, Former Senior Vice President, Chief Patient Access Officer, Sobi
Professor Michael Linden, Former VP Gene Therapy & Head, GMI, Pfizer
Yann Le Cam, Chief Executive Officer, EURORDIS
Dr Ségolène Aymé, Founder of Orphanet, Emeritus Research Director, INSERM
Dr Bruno Sepodes, Chair of COMP, EMA
Sheela Upadhyaya, Assoc. Director Highly Specialised Technologies, National Institute For Health and Care Excellence
Alastair Kent, Director, Genetic Alliance UK
Dr Carlo Incerti, SVP, Head of Global Medical Affairs, CMO, Genzyme, A Sanofi Company
Dr Birgitte Volck, SVP, Head of R&D Rare Diseases, GSK
Dr Mathew Pletcher, Head of Rare Disease Discovery, Roche
Dr M Ken Kengatharan, Managing Director, Atheneos Capital
Dr Pedro Franco, Former Scientific Administrator, EMA

If you are interested in attending make sure to register today and benefit from the 10% partner discount. Simply use the voucher code SPTX when you register online http://bit.ly/2LFtuiq
Contact:
World Orphan Drug Congress Europe 2018
T: +44 (0) 207 092 1257
E: issa.mauthoor@terrapinn.com

Superbugs & Superdrugs USA
2018-11-12 - 2018-11-13 | Renaissance Woodbridge Hotel, 515 US Highway 1 South, Iselin, NJ, United States
Antimicrobial resistance, leading to the development of superbugs, is a major threat to public health and continues to increase as a problem, due to continued misuse of antibiotics. With pharmaceutical companies showing less focus on the development of new antibiotics, several incentive initiatives have been set up – CARBX, BARDA, IMI (EU) – in order to encourage reinvestments.

To address the ever-growing need of informative and thought-provoking discussions, Superbugs & Superdrugs USA conference will offer a jam-packed agenda with presentations from key industry leaders and up-and-coming thinkers, within the field.
This years’ Superbugs & Superdrugs USA conference programme will help participants to learn about pathogen focused drug development; discover the best methods to overcome bacterial resistance through novel modes of action; discuss the state of developments within the antifungal space; develop an understanding of funding opportunities which support antibacterial research and development; gain insight into new techniques through case-study examples of rapid diagnostic methods currently being used within the field, making this event the perfect platform to strengthen knowledge in key principles.
Speakers include:

Anthony Simon Lynch, Senior Scientific Director, Janssen
William Weiss, Director, Pre-Clinical Services, UNT Health Science Center
Tina Guina, Program Officer, Drug Development Section, NIAID/NIH
Mark Albrecht, Project Officer, HHS/ASPR/BARDA
Antonio DiGiandomenico, Principal Scientist, MedImmune
Andrew Tomaras, VP & Director of Microbiology, Bacterioscan
Dan Pevear, Sr Vice President & Director of Microbiology, VenatoRx
Ian Friedland, Clinical Consultant, ex-CMO, Achaogen

Plus, topical workshops on November 14:

Rapid diagnostics for drug resistance: Are we there yet?
Avoiding the post antibiotic era: the challenges and solutions to successful commercialisation of new antibiotics

Further details at http://www.superbugs-usa.com/PJWL
Twitter – @SMIpharm & #smibugs
LinkedIn – SMi Pharma

World ADC San Diego
2018-11-12 - 2018-11-15 | Marriott Marquis San Diego, 333 W Harbor Dr, San Diego, CA, 92101, United States
9th Annual World ADC San Diego 2018 | 12-15 November, 2018 | Marriott Marquis & Marina, San Diego, CA
Maximizing the clinical therapeutic window of antibody-drug conjugates is a challenge we’re continuing the grapple with.
As such, there is a lot to be shared and discussed at this year’s 9th Annual World ADC San Diego.

Since it’s conception in 2009 World ADC has risen to become the world’s leading and most comprehensive ADC meeting. The pinnacle event for thought-leading ADC drug developers.
Offering you an unparalleled learning and networking experience this year’s conference will share the very latest research advances, enabling you to maximize the clinical therapeutic window of your ADC candidate.
Join over 650 drug developers across 220 organizations from the likes of Daiichi Sankyo,Genentech, Bristol Myers Squibb, Immunomedics, Immunogen, Formation Biologics, FDA and Sutro Biopharma to:

Hear unpublished data for the first time during the new Late Breaking Abstracts session

Access superior breadth of ADC research across 4 streams of parallel learning across discovery, development, clinical and manufacturing

Communicate your new results, benchmark against your peers and gain invaluable feedback from the scientific community during the Poster Session

Gain tangible actions from discussing your challenges in one of the thirteen discussion led workshops

Recognise your peer’s achievements and maybe yours?during the 5th Annual World ADC Awards ceremony

Find out more https://info.hansonwade.com/worldadcsandiego
Download Full Agenda https://info.hansonwade.com/worldadcguide

Biosimilars USA
2018-11-14 - 2018-11-15 | RENAISSANCE WOODBRIDGE HOTEL, NEW JERSEY, United States
Building on the success of previous events, SMi proudly announces the return of its 5th Annual Biosimilars USA Conference, taking place in New Jersey, USA on the 14th and 15th November 2018 and chaired by Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals USA.

The event will gather a global audience of biosimilar experts and industry-thought leaders to discuss biosimilar manufacturing and commercialization considerations specific to the U.S.
Fresh from the press: On March 7th, 2018, the U.S.-FDA’s Commissioner, Scott Gottlieb, MD, announced that Biosimilar medicines are now a top priority for the FDA. Join us this November to learn how to take advantage of the FDA’s focus on biosimilars, accelerate your biosimilar pipeline and achieve FDA approval.
Hear from a selection of carefully handpicked keynote addresses and case studies presented to you by top manufacturing and leading distributors of market approved biosimilars, as they offer a unique insight into the areas of manufacturing, commercialization, device design, uptake, switching, interchangeability, and regulations.
This event is CPD accredited.
#SMiBioSimUSA
PLUS TWO INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS
Tuesday 25th September 2018, Copthorne Tara Hotel, Central London, UK
08.30 – 12.30
Workshop A: Decoding how Stakeholders may Drive Biosimilar Adoption
Workshop Leaders: Tucker Herbert, Manager, ZS Associates
Christina Corridon, Associate Principal, ZS Associates
13.30 – 17.00
Workshop B: Dealing with Life Sciences Patents at the PTAB
Workshop Leaders: Ha Kung Wong, Partner, New York, Fitzpatrick, Cella, Harpper & Scinto
John Kirkland, Director, Intellectual Property, Alkermes, Inc.
WHO SHOULD ATTEND
Medical Directors, Scientific Directors, VP’s, Directors, Managers, Team Leaders, Partners, Consultants and Attorneys of:
Biosimilars, Biobetters, Biopharmaceuticals, Biostatistics, Business Alliances, Business Development, Clinical Operations, Commercial, Decision Analytics, Global Intelligence, Global Operations, Managed Markets and Trade Relations, Market assess, Marketing, Patient & Physician Services, R&D Policy, Regulatory Affairs, Scientific Affairs, and anyone else who works within the biosimilars industry!
EARLY BIRD-RATES
BOOK BY JUNE 29TH AND SAVE US$300
BOOK BY SEPTEMBER 28TH AND SAVE US$100
To learn more about Biosimilars USA, and to register online, visit www.biosimilars-usa.com/pharmajournalist

3rd Skin Microbiome Congress
2018-11-14 - 2018-11-15 | ILEC Conference Centre and Ibis London Earls Court, 47 Lillie Road, London, SW6 1UD, United Kingdom
3rd Skin Microbiome Congress | 14-15 NOVEMBER, 2018 | LONDON, UNITED KINGDOM
The average consumer uses up to 515 synthetic chemicals daily to eradicate dermalogical concerns – how can this be good for skin? Introducing the first European Skin Microbiome Congress.

Following the success of the inaugural Skin Microbiome Congress in Boston in May and our second congress in San Francisco in September, don’t miss the opportunity to join 200+ industry experts from multinational pharmaceutical, beauty and personal care companies, independent skincare brands and innovative biotechs to discuss the emerging relationship between the skin microbiome and healthy skin.
Discover the potential of prebiotic, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Take advantage of:
Effective Networking – Pre-schedule private meetings with any individual or company onsite using the online meeting scheduler application
Cutting Edge Research – Discover the latest advancement in therapeutic & cosmetic products containing live bacteria, bacterial extracts, or active ingredients to promote & protect the skins microbiome
Consumer Trends – Understand how consumers trends towards natural, organic products and active beauty are shaping the evolution of products adapted to the skin microbiome
Clinical Trials – Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeutics
Competitive Edge – Determine how to differentiate your product line & seize this market opportunity, gaining market share with scientifically backed products
Regulation – Understand the different paths to market & regulatory considerations necessary to launch a cosmetic or therapeutic product
With an increasing consumer trend towards natural products, what’s more natural than harnessing the bacteria on your skin? Don’t miss your chance to understand the next generation of natural skincare products!
To learn more about 3rd Skin Microbiome Congress, and to register online, visit www.skinmicrobiomecongresseu.com
CONTACT:
+44 (0)20 3696 2920
events@kisacoresearch.com

Marketing and Customer Experience USA
2018-11-14 - 2018-11-15 | Sofitel Philadelphia Hotel, 120 South 17Th Street, Philadelphia, PA, 19103, United States
Redefine your customer relationships to become a valued healthcare partner
eyeforpharma’s Marketing and Customer Experience USA (November 14-15 2018, Philadelphia) breaks down the model you need to raise the bar on customer experience and get ROI on marketing strategies.

Digital is dead. Theoretical discussions about the power of technology are obsolete. But pharma has the potential to transform its customer relationships given the right tools.
eyeforpharma is bringing a practical guide to pharma marketers – a first of its kind event that will bring together all stakeholders and deliver a roadmap to revitalizing customer relationships. Go beyond theoretical discussions around digital innovation and discover how you can transform customer engagement with technology – and most importantly how to future-proof your business model and culture.

Go beyond conventional digital: Harness innovations that solves patient and physician problems to increase your product’s value proposition and rebuild your reputation
Exceed customer expectations, dominate the market
Ensure the latest guidance and inspiration is always available for a generation that expects on-demand access to information – and become the go-to source for your customers
Big data, big deal: refine analytics for deeper insights that put you on top
Don’t shout louder, find smarter insights to form a deeper understanding of customer needs for differentiated, targeted content
Secure workforce buy-in and customer backing will follow
Invest in your people with first-rate training and create a culture that will make your workforce want to shout about your products, so your employees become your best advocates

With the latest case studies, panels led by customers and out of industry expert sessions that will help you create the ultimate, effortless customer experience– this is the event to ensure your business is ready to dominate the market.
Some of the job roles and functions attending will be Digital, Customer Experience, Centers of Excellence, Innovation Strategists, Sales & Marketing Executives, Patient Engagement, IT leadership, Brand Managers, MCM and Innovation Heads.
To learn more about this event, and to register online, visit http://bit.ly/2LIaO1K

17th Pharmacovigilance 2018
2018-11-15 | Kohinoor Continental Hotel, Andheri Kurla Road, Andheri ( E ), Mumbai – India, Mumbai, 400059, India
17th Pharmacovigilance 2018
15th November 2018, Kohinoor Continental Hotel, Mumbai, India
17th Pharmacovigilance 2018 focuses on the advancements in Pharmacovigilance, Risk Management, and Drug Safety. IT emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors.
SPONSORS:

Principal Sponsor: Apcer Life Sciences
Gold Sponsor: Syneos Health
Exhibitors: Ab Cube, Medvigil, Elsevier

KEY SPEAKERS:
DDC(I), CDSCO (HQ), Indian Drug Manufacturers’ Association (IDMA), FDA Maharashtra Lupin , Abbott, Merck Sharp & Dohme, Novartis , Abbott, AstraZeneca, Piramal, Reliance Life Sciences, GSK, Mylan Laboratories, Nishith Desai Associates, , Roche Pharmaceuticals, CliniSearch, GSK, Member Editorial Board Journal of Generic Medicines, England, Veeda Clinical Research, AWINSA Life Sciences,
CONFERENCE REGISTRATION:
In order to register you can simply Email: kavitha@virtueinsight.co.in or Tel: +91 44 24762472

Early Bird Discounted Price (Ends 12th October 2018 ) – 1 Delegate Pass – (INR 10,000 + GST (18%) per delegate)
Standard Price (13th October 2018 Onwards) – 1 Delegates – (INR 15,000 + GST (18%) per delegate)
Conference Sponsor, Exhibition Stall (Booth) and a paid Speaker slots are also available. We also have some sponsorship opportunities available for the event, which gives you an opportunity to speak/exhibit, and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts.

Get more from the event, with a broader scope bringing the whole communications value chain together.

The 4BIO Summit: Europe
2018-11-27 - 2018-11-28 | Rotterdam, Netherlands (venue TBC)
4Bio Europe will feature the most cutting-edge research and technology developments in the fields of qPCR/dPCR, NGS, microfluidics and gene editing. Scientific advancements coupled with cost reductions in these four areas of research have contributed to the improved diagnosis, monitoring, and treatment of disease.
With similar and shared methods and applications across the four main themes of the meeting, 4Bio Europe will provide a multi-disciplinary forum in which to discover crossover in your research, attend the latest cutting-edge talks that appeal to you mostand network with your peers and discover solutions to the whole spectrum of your research all in one location.
To learn more about this event, and to register online, visit https://goo.gl/Vza4PY

ICI Europe Summit 2018
2018-11-27 - 2018-11-29 | The Sofitel Berlin Kurfuerstendamm, Augsburger Strasse 41, Berlin, 10789, Germany
ICI Europe Summit 2018 | 27-29 November 2018 | The Sofitel Berlin Kurfuerstendamm, Berlin
Evidencing How Checkpoint Combinations Can Enhance Every Stage of the Cancer Immunity Cycle
Rather than covering a random selection of immuno-oncology combinations, 4th Annual ICI Europe Summit focuses on how checkpoint combinations can impact every stage of the cancer immunity cycle, enhancing the long-term success of immuno-oncology drug development.

Cutting through the noise and hype around the immuno-oncology field, this industry focused conference will use the cancer immunity cycle as a framework from which to investigate the most promising immuno-oncology approaches.
Don’t miss this opportunity to join Merck, Genentech, AstraZeneca, Bayer, Roche and many other leading organisations, to empower you to make the right decisions with your IO pipeline and lay the foundations for your future success.
Access the complete programme to find out more about the speakers and what they will discuss: https://bit.ly/2Rr4TSI
Pharma Journalist readers are eligible for 10% discount to attend. Book online quoting VIP Code 9710PJ and you’ll automatically receive the discount. Applies to new bookings only. Cannot be used in conjunction with other offers. T&Cs apply.

4th Annual Oncolytic Virotherapy Summit
2018-12-04 - 2018-12-06 | Hilton Boston Back Bay Hotel, 40 Dalton St, Boston, MA, 02115, United States
The 4th Oncolytic Virotherapy Summit is dedicated to improving the commercial success of oncolytic viruses, in stand-alone and combination therapies.

As many oncolytic viruses progress through the clinical pipelines, drug developers need to ensure that their therapies are safe, efficacious and commercially viable. Make sure you stay ahead of the game and join Oncolytic Virotherapy Summit, where you will have an opportunity to pick the brains of 100+ senior industry peers and tackle your challenges in discovery, clinical development, manufacturing and regulations of oncolytic virotherapy.
This year we will be incorporating commercial insights from companies such as Merck, Virogen, Sagetis, Lokon Pharma, Replimmune, Western Oncolytics, DNAtrix and many more, which will allow you to learn from their case studies and improve your development strategies. Participate in the interactive roundtable and workshops to build strategies that maximise success in the clinic and commercially.
Sounds interesting? Find out more – get free event brochure here: http://bit.ly/2KzCLIh

Skin Microbiome Asia
2018-12-04 - 2018-12-05 | Hong Kong, Venue TBC
Skin Microbiome Asia | 4-5 December 2018 | Hong Kong – As K-Beauty and J-Beauty continue to storm the world, beauty start-ups are also emerging from Australia, India and across Southeast Asia. China, Singapore and Hong Kong remain mecca markets for international companies launching products into the region. There has never been a better time for cosmetics professionals to meet in Asia.

150+ industry experts will be gathering in Hong Kong this December to learn about the science behind the products from companies like Unilever, Cosmax, Mother Dirt and more.
Join multinationals, independent beauty brands, sequencing companies, regulators, pharma & biotech companies and academia to build your network throughout Asia Pacific.
Interested to learn more? Take a look at our agenda here: http://bit.ly/SkinAsiaAgenda
Or take advantage of our Super Early Bird Pricing and book your pass here: http://bit.ly/SkinAsiaRegistration
Praise for the event:
“An incredible event… Fast paced and full of new and relevant information from a variety of perspectives, each of which provide a complete and extensive snapshot of the industry and the future of microbiome friendly products” – TrūAura Beauty
“The value of this conference was absolutely unparalleled! I not only saw many old friends, collaborators and partners, but also met many new ones as well.” – ProdermIQ
To learn more about Skin Microbiome Asia, and to register online, visit www.skinmicrobiomecongressasia.com

CBI’s Clinical Trial Agreement Series
2018-12-04 - 2018-12-06 | Wyndham Philadelphia Historic District, 400 Arch Street, Philadelphia, PA, 19106, United States
Designed to maximize your time out of the office, CBI’s three-day Clinical Trial Agreement conference series allows your team to select the content that best meets your business objectives. Attend your preferred event or BOTH for maximum value, learning and benchmarking. The Clinical Trial Legal and Contracting Forum, taking place December 4-5 in Philadelphia, serves as the only meeting that is singularly focused on the detailed legal and contracting issues that relate to clinical agreements of all types. The Clinical Trial Financial Management summit, taking place December 5-6 in Philadelphia, is designed to arm sponsors, CROs, AMCs and sites with the insights they need to develop, negotiated and manage the financial aspects of clinical trial agreements.
To learn more about this event, visit www.cbinet.com/ctafinance

BioFIT
2018-12-04 - 2018-12-05 | Lille Grand Palais 1 boulevard des Cités Unies 59000 Lille, FRANCE, France
EARLY-STAGE INNOVATIONS | ACADEMIA-INDUSTRY COLLABORATIONS | TECHNOLOGY TRANSFER | SEED INVESTMENT
With the highest attending rate of TTOs, research institutes and academia together with big pharma, emerging and small biotech, diagnostics companies, pre-seed / seed / Series A investors, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovations in the field of Life Sciences. BioFIT is also the European marketplace for pre-seed, seed and Series A investment in Life Sciences.
WHY ATTEND BIOFIT?
Out of 1,000 BioFIT attendees, 1,000 deals have been generated. The breakdown in terms of nature of deals is the following:

35% of collaborative research projects
30% of licensing deals
15% of equity investment deals
20% of services deals

Estimate based on the measurement of 2015 and 2016 delegates’ outcomes
KEY FIGURES:

1,200+ delegates
800+ organisations
35+ countries represented
1,000 deals generated in 2017

INSIDE THE EVENT:

A business convention with pre-qualified one-to-one meetings (partneringONE platform from EBD Group)
Identification of would-be CEOs
Conferences and roundtable discussions
Oral presentations of start-ups and licensing opportunities stemming from academia
An exhibition area
Informal networking evenings

Website: www.biofit-event.com
Twitter: @BIOFIT_EVENT
Contact:
Margaux Satola
Business Development Manager
msatola@eurasante.com
+33 (0)3 59 39 01 82

The Digital Pathology Congress
2018-12-06 - 2018-12-07 | London Heathrow Marriott Hotel, London, UK
The congress will have expanded coverage of new areas such as AI and computational pathology alongside the latest case studies and applications. To complement the latest scientific presentations, the conference will comprise of a vibrant exhibition room full of technology providers showcasing their technologies and other solutions; networking breaks allowing interaction with your peers; poster presentation sessions; and incisive Q&A panel discussions. Whether looking to hear more about the adoption and integration of digital pathology; seeking collaborations and tools to increase workflow; or uncover the latest developments in automated image analysis; the Congress is one not to be missed!
To learn more about this event, and to register online, visit https://goo.gl/42HTeh
